• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?

UPS and FDX are both in serious rally mode, yet in very different places in terms of technical development.
By STEPHEN GUILFOYLE
May 04, 2021 | 07:48 AM EDT
Stocks quotes in this article: ATVI, LYFT, RNG, TMUS, COP, DD, CVS, CMI, LDOS, PFE, SYY, VMC, FDX, UPS, KEX, MATX, BNTX, MRNA, JNJ, AZN, VZ, CS

I've been waiting here to be your guide

So come

Reveal the secrets that you keep inside

Step up !

No one leaves until the night is done

The amplifier starts to hum

The carnival has just begun

-- Stanley, Cuomo (Kiss, from "Psycho Circus") 1998

Active Monday

For days it seems, maybe weeks, we have dug into the muck with nothing but bare hands. We have discussed deeply the nuances of fiscal policy, of monetary policy and the like. We have made all earnest attempts to reawaken public thirst for cognitive nuance. To broaden the gap between those wanting, even needing to deepen their own interpretation of real-world impacts made possible through the implementation of one school of economic concept over another.

The gap? Indeed, the gap broadens between those who crave a more deeply rooted understanding and those who don't even know that there is more that must be understood. More than one way to get things done. More than one way to get people that in most cases, even granted ability, would choose an easier ignorance over a more uncomfortable quest for depth.

Monday trading volumes contracted from Friday's "final day of the month action." That said, the market was active for a Monday, at least a recent Monday. The day turned out greener for the small-to mid-caps than it did for the broader large-cap indices. Narrower large-cap indices such as the Dow Jones Industrials and the Dow Jones Transportation Average did well, in fact very well for the transports in particular, but perhaps not in the way that you have become accustomed to think.

Bond traders bought the long end of the Treasury curve on Monday, while actually selling the short end. The result was a flatter yield curve. The U.S. dollar softened. Capital flows expectedly moved toward the Energy and Materials sectors, thus chief beneficiaries could be found in delivery services such as FedEx (FDX) and United Parcel Service (UPS) as well as in maritime transport operations such as Kirby (KEX) and Matson (MATX) . The trucker and the rails also rallied but to a less significant degree, while traders sold the airlines.

Are You Ready?

Put all theory and concept aside for a morning, and just try to make some money? All right then. So it is. We sheath that most sacred weapon of them all, the mighty Ka-bar (after a glorious re-sharpening with a forty-year old stone) in place just ahead of the right-side canteen, we strap the survival blade (upside down of course) to the left-side Y-strap of our harness, boot knife in place on right side, throwing knives secured (think I'm telling you where, keep dreamin'). Ammo? Well, we really weren't thinking about making any noise. Now, we are just about ready. Ready to rock. So, let's move out.

Take a look at UPS and FDX because they are both in serious rally mode, and I am long both of them. Yet, they are in very different places in terms of technical development.

UPS reported last Tuesday and hit the ball out of the park. FDX reported in March and does not step into the batter's box again until June.

FedEx broke out of a cup-and-handle pattern on Monday that begins back in December. Readers can clearly see the $295 pivot, which in all likelihood might be tested at least once prior to release. That said, Relative Strength is strong, but not overbought, while the daily Moving Average Convergence Divergence (MACD) is in very bullish shape. We are moving our target price here up to $354 from $340, and our panic-point up to $274 (50-day SMA) from $265.

Now, United Parcel Service is in a far more mature place in terms of pattern development, as we display below.

Note that UPS is now a week out of its breakout from an eight-month basing pattern with a pivot of $176. That pivot, you might recall, provided us with a target price of $212. Where did UPS close on Monday? That's right.. $212.20.

Note also, that as this name has reached target, Relative Strength appears grossly overbought, while the daily MACD at the same time seems quite extended. In addition, traders and algos alike can still see the gap created by last week's earnings-induced pop.

I won't tell you what to do, but I will tell you that I fully intend to take a little something off of my UPS long here at target. That's discipline, or at least that's my code of discipline. Doesn't mean that I don't like UPS, just means that the bananas are yellow, whereas for FDX, the bananas are still green.

The Cavalry

Such swagger. The United States Cavalry. Blue Stetsons with gold trim, and stirrups attached to their boots. Thinking horse soldiers of the late 1800s? This is modern day. These guys still dress like that, and still think like that. God bless the United States Cavalry.

By the way, a different kind of cavalry is on the way. First I saw a report in The New York Times that the FDA (Food and Drug Administration) was preparing to authorize (for Emergency Use) the Pfizer (PFE) /BioNTech (BNTX) COVID-19 vaccine for American adolescents aged 12 thru 15 years.

As if that's not interesting enough, we learned later in the day that the Biden administration is backing the export of U.S. manufactured COVID-19 vaccines to nations where demand is greater than it currently is in the U.S. India, a nation currently under viral siege, has already approved the Pfizer, Moderna (MRNA) and Johnson & Johnson (JNJ) vaccines, while Canada and Mexico both look forward to, and expect to see U.S. vaccines, Pfizer's in particular, imported into those nations in short order.

Let's face it, the vaccinated world is going to have to vaccinate the un-vaccinated world if this scourge is ever going to really go away. That's just plain science. This is not even due to our national benevolence, but because allowing this virus to spread and mutate anywhere on the planet threatens the immunity of all.

I am hardly a scientist but I have studied this virus as well as all of the vaccines and therapeutics created in the fight against it since becoming ill myself. My information is anecdotal at best, but it appears to me that the Pfizer and Moderna vaccines (the messenger RNA) vacaciones) are of the highest quality, with minimal (that we know of) lasting side effects, and also have large capacity for manufacture. The JNJ jab also can be manufactured in size, and from what I read of the Russian vaccine, Sputnik V, seems like it's working. Then there is also the AstraZeneca (AZN) shot.

Getting It Done

We'll get this done, but the effort is a long way from over. I hear neighbors who never had the virus enter their home talk about how tough the last year has been and I think back to my sickest days, and I read of some poor kid in India, half sick herself trying to find oxygen for her father and grandfather who both eventually die, and I think to myself: I hope these folks never find out how dark this beast is.

For those readers who have faced off with this monster, you know. We have all have had that moment, that day, or that week that we thought that it might really be all over.... and prayed to God that our children aren't the ones that find us.

I told you at the start of all of this that Pfizer would be first across the goal-line. They were. I told you that Pfizer would save the world. They might. The stock has done little for over a year, as there are certain hurdles such as expiring patents to be overcome. That said, this might be the break that the world and the stock has needed.

Pfizer reports this morning. More than how good the numbers are, what is said concerning both youth and global vaccination is what will determine whether or not this train is leaving the station.

On the Bright Side...

A) You're not the guy who bought AOL and Yahoo for Verizon (VZ) in 2015 and 2017, respectively. Could be the worst trade since Credit Suisse (CS) placed such a high valuation on DLJ Direct, or since your moron author thought CMGI was a good idea.

B) According to sources, citing a memo from the desk of NYSE COO Michael Blaugrund, the New York Stock Exchange plans to (on May 10) permit companies with trading floor-based staff to increase headcount to 100% if those employees are vaccinated. Those vaccinated will also be excluded from random testing and be permitted to remove their masks while seated at the workstations (in their booths), provided social distancing is maintained.

Economics (All Times Eastern)

08:30 - Balance of Trade (Mar): Expecting $-74.3B, Last $-71,1B.

08:55 - Redbook (Weekly): Last 13.9% y/y.

10:00 - Factory Orders (Mar): Expecting 1.3% m/m, Last -0.8% m/m.

16:30 - API Oil Inventories (Weekly): Last +4.319M.

The Fed (All Times Eastern)

13:00 - Speaker: San Francisco Fed Pres. Mary Daly.

Today's Earnings Highlights (Consensus EPS Expectations)

Before the Open: (COP) (0.48), (DD) (0.76), (CVS) (1.71), (CMI) (3.51), (LDOS) (1.47), (PFE) (0.78), (SYY) (0.21), (VMC) (0.45)

After the Close: (ATVI) (0.70), (LYFT) (-0.55), (RNG) (0.25), (TMUS) (0.63)

(Dupont and UPS are holdings in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells these stocks? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Guilfoyle was long MRNA, JNJ, UPS, FDX, PFE equity.

TAGS: Earnings | Futures | Indexes | Investing | Markets | Small Cap | Stocks | Trading | U.S. Equity | Coronavirus

More from Stocks

Does the Big Bounce Mean More to Come? Let's See What Drove the Move

James "Rev Shark" DePorre
Jun 24, 2022 4:42 PM EDT

Much of the rally can be attributed to structural reasons, not fundamentals, technicals, or even macro ones.

MongoDB Is Poised for a Rally

Bruce Kamich
Jun 24, 2022 2:15 PM EDT

Here's our initial upside price target for MDB which provides a general purpose database platform.

See That Down the Road? It's the Big 'Green' Bubble, Ready to Pop

Jim Collins
Jun 24, 2022 1:30 PM EDT

Environmental, social, and corporate governance has created a monster and gullible investors should hit the brakes on their EVs and run from the Washington technocrats while they have the chance.

When Times Are Tough, These 3 Mega-Caps Should Deliver the Dividends

Bob Ciura
Jun 24, 2022 1:00 PM EDT

Here's why in recessions and bear markets, the right mega-cap stocks can offer security -- and good yields.

Atlassian Is Now in the Latter Stages of Its Decline

Bruce Kamich
Jun 24, 2022 12:22 PM EDT

Let's check the charts and indicators.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:10 AM EDT PAUL PRICE

    More Insider Buying in American Woodmark (AWMD)

    American Woodmark , which I've discussed here fr...
  • 08:55 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 10 personality traits of successful traders an...
  • 12:08 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10

    As a Portfolio Name Agrees to a Merger, Here's Our...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login